On September 6, 2022 Alligator Bioscience (Nasdaq Stockholm: ATORX) reported that senior company representatives will participate in the following scientific conferences during September 2022 (Press release, Alligator Bioscience, SEP 6, 2022, View Source [SID1234619042]):

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

ESMO Congress 2022, September 9 – 13, Paris
Malin Carlsson, Executive Vice President & Chief Operating Officer at Alligator Bioscience, and Karin Nordbladh, Director of Clinical Operations at Alligator Bioscience, to attend in-person.
Registration for the conference is open here.
AACR Special Conference on Pancreatic Cancer, September 13 – 16, Boston
Yago Pico de Coaña, Medical Science Director at Alligator Bioscience, to present complete data from the Phase 1b dose escalation part of mitazalimab OPTIMIZE-1 Phase 1b/2 trial in first-line metastatic pancreatic cancer.
Registration for the conference is open here.
13th World Bispecific Summit, September 20 – 22, Boston
Laura von Schantz, Vice President of Discovery at Alligator Bioscience, to give a presentation entitled "Kick-Starting Tumor Specific T Cell Cross-Priming Using Neo-X-Prime Bispecific Antibodies Targeting CD40" at 01:45 pm EDT / 07:45 pm CEST on September 21.
Registration for the conference is open here.
Immuno UK, September 29-30, London
Peter Ellmark, Chief Scientific Officer at Alligator Bioscience, will give a presentation entitled "Targeting the Myeloid Population In The Tumour Microenvironment" at 01:45 pm BST / 2:45 pm CEST on September 30.
Registration for the conference is open here.